Wachtell and Skadden lead Pfizer/Array deal

Pfizer has announced that it will purchase Colorado-based Array Pharmaceuticals in an $11 billion acquisition that adds to Pfizer’s cancer treatment portfolio.

Get unlimited access to all Global Competition Review content